Johnson Matthey PLC (LON:JMAT - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,513.75 ($20.22) and traded as high as GBX 1,763 ($23.55). Johnson Matthey shares last traded at GBX 1,759 ($23.50), with a volume of 320,966 shares.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank raised their target price on Johnson Matthey from GBX 1,800 ($24.04) to GBX 1,950 ($26.05) and gave the stock a "hold" rating in a research report on Monday, July 21st.
Get Our Latest Report on Johnson Matthey
Johnson Matthey Price Performance
The stock has a market capitalization of £2.96 billion, a PE ratio of 30.07, a P/E/G ratio of 49,242.50 and a beta of 0.95. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. The stock's 50-day moving average is GBX 1,775.56 and its 200 day moving average is GBX 1,513.75.
Johnson Matthey (LON:JMAT - Get Free Report) last posted its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($1.99) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. As a group, equities analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.